Literature DB >> 33959889

Telomere Length and Oxidative Stress in Patients with ST-Segment Elevation and Non-ST-Segment Elevation Myocardial Infarction.

Nihal Inandiklioğlu1, Vahit Demir2, Müjgan Ercan3.   

Abstract

PURPOSE: The telomere length is shown to act as a biomarker, especially for biological aging and cardiovascular diseases, and it is also suggested that with this correlation, increased exposure to the oxidative stress accelerates the vascular aging process. Therefore, this study aims to understand the correlation between the plasma oxidative stress index (OSI) status and leukocyte telomere length (LTL) and cardiologic parameters between the ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI) groups.
METHOD: One hundred one newly diagnosed patients with STEMI (n = 55) and NSTEMI (n = 46) were included in the study, along with 100 healthy controls who matched the patients in terms of age and gender. Plasma total antioxidant status (TAS), total oxidant status (TOS), and LTL were measured.
RESULTS: When LTL, TAS, TOS, and OSI values were evaluated between the patient and control group, OSI (p = 0.000) and LTL (p = 0.05) values were statistically significant in the patient group compared to the control group. Evaluation was conducted to understand whether there is a difference between the STEMI and NSTEMI groups. The plasma OSI (p = 0.007) and LTL (p = 0.05) were found to be significantly lower in STEMI patients. However, LTL and OSI results were not statistically significant in NSTEMI patients.
CONCLUSION: This is the first study evaluating telomere length and oxidative stress in STEMI and NSTEMI patients in Turkey. Our results support the existence of short telomere length in STEMI patients. Future studies on telomere length and oxidative stress will support the importance of our findings.
© 2021. Springer Nature Switzerland AG.

Entities:  

Keywords:  Acute myocardial infarction; Non-ST-segment elevation myocardial infarction; Oxidative stress; ST-segment elevation myocardial infarction; Telomere length

Mesh:

Year:  2021        PMID: 33959889     DOI: 10.1007/5584_2021_638

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  37 in total

1.  Telomere measurement by quantitative PCR.

Authors:  Richard M Cawthon
Journal:  Nucleic Acids Res       Date:  2002-05-15       Impact factor: 16.971

Review 2.  Association between shortened leukocyte telomere length and cardiometabolic outcomes: systematic review and meta-analysis.

Authors:  Matthew J J D'Mello; Stephanie A Ross; Matthias Briel; Sonia S Anand; Hertzel Gerstein; Guillaume Paré
Journal:  Circ Cardiovasc Genet       Date:  2014-11-18

3.  Oxidative Stress and Spontaneous Reperfusion of Infarct-Related Artery in Patients With ST-Segment Elevation Myocardial Infarction.

Authors:  Abdurrezzak Börekçi; Mustafa Gür; Caner Türkoğlu; Şahbettin Selek; Ahmet Oytun Baykan; Taner Şeker; Hazar Harbalıoğlu; Betül Özaltun; İlyas Makça; Nurten Aksoy; Yavuz Gözükara; Murat Çaylı
Journal:  Clin Appl Thromb Hemost       Date:  2014-08-12       Impact factor: 2.389

Review 4.  Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection.

Authors:  Elizabeth H Blackburn; Elissa S Epel; Jue Lin
Journal:  Science       Date:  2015-12-04       Impact factor: 47.728

5.  Leukocyte telomere length is associated with high-risk plaques on virtual histology intravascular ultrasound and increased proinflammatory activity.

Authors:  Patrick A Calvert; Tze-Vun Liew; Isabelle Gorenne; Murray Clarke; Charis Costopoulos; Daniel R Obaid; Michael O'Sullivan; Leonard M Shapiro; Duncan C McNab; Cameron G Densem; Peter M Schofield; Denise Braganza; Sarah C Clarke; Kausik K Ray; Nick E J West; Martin R Bennett
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-06-16       Impact factor: 8.311

6.  The association of plasma oxidative status and inflammation with the development of atrial fibrillation in patients presenting with ST elevation myocardial infarction.

Authors:  Hasan Aydin Bas; Fatih Aksoy; Atilla Icli; Ercan Varol; Abdullah Dogan; Dogan Erdogan; Ibrahim Ersoy; Akif Arslan; Hatem Ari; Nihal Bas; Recep Sutcu; Mehmet Ozaydin
Journal:  Scand J Clin Lab Invest       Date:  2016-12-01       Impact factor: 1.713

7.  Recommendations on the Echocardiographic Assessment of Aortic Valve Stenosis: A Focused Update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography.

Authors:  Helmut Baumgartner; Judy Hung; Javier Bermejo; John B Chambers; Thor Edvardsen; Steven Goldstein; Patrizio Lancellotti; Melissa LeFevre; Fletcher Miller; Catherine M Otto
Journal:  J Am Soc Echocardiogr       Date:  2017-04       Impact factor: 5.251

8.  Telomere length and cardiovascular risk factors in a middle-aged population free of overt cardiovascular disease.

Authors:  Sofie Bekaert; Tim De Meyer; Ernst R Rietzschel; Marc L De Buyzere; Dirk De Bacquer; Michel Langlois; Patrick Segers; Luc Cooman; Piet Van Damme; Peter Cassiman; Wim Van Criekinge; Pascal Verdonck; Guy G De Backer; Thierry C Gillebert; Patrick Van Oostveldt
Journal:  Aging Cell       Date:  2007-10       Impact factor: 9.304

9.  Association between telomere length in blood and mortality in people aged 60 years or older.

Authors:  Richard M Cawthon; Ken R Smith; Elizabeth O'Brien; Anna Sivatchenko; Richard A Kerber
Journal:  Lancet       Date:  2003-02-01       Impact factor: 79.321

10.  Identification of seven loci affecting mean telomere length and their association with disease.

Authors:  Veryan Codd; Christopher P Nelson; Eva Albrecht; Massimo Mangino; Joris Deelen; Jessica L Buxton; Jouke Jan Hottenga; Krista Fischer; Tõnu Esko; Ida Surakka; Linda Broer; Dale R Nyholt; Irene Mateo Leach; Perttu Salo; Sara Hägg; Mary K Matthews; Jutta Palmen; Giuseppe D Norata; Paul F O'Reilly; Danish Saleheen; Najaf Amin; Anthony J Balmforth; Marian Beekman; Rudolf A de Boer; Stefan Böhringer; Peter S Braund; Paul R Burton; Anton J M de Craen; Matthew Denniff; Yanbin Dong; Konstantinos Douroudis; Elena Dubinina; Johan G Eriksson; Katia Garlaschelli; Dehuang Guo; Anna-Liisa Hartikainen; Anjali K Henders; Jeanine J Houwing-Duistermaat; Laura Kananen; Lennart C Karssen; Johannes Kettunen; Norman Klopp; Vasiliki Lagou; Elisabeth M van Leeuwen; Pamela A Madden; Reedik Mägi; Patrik K E Magnusson; Satu Männistö; Mark I McCarthy; Sarah E Medland; Evelin Mihailov; Grant W Montgomery; Ben A Oostra; Aarno Palotie; Annette Peters; Helen Pollard; Anneli Pouta; Inga Prokopenko; Samuli Ripatti; Veikko Salomaa; H Eka D Suchiman; Ana M Valdes; Niek Verweij; Ana Viñuela; Xiaoling Wang; H-Erich Wichmann; Elisabeth Widen; Gonneke Willemsen; Margaret J Wright; Kai Xia; Xiangjun Xiao; Dirk J van Veldhuisen; Alberico L Catapano; Martin D Tobin; Alistair S Hall; Alexandra I F Blakemore; Wiek H van Gilst; Haidong Zhu; Jeanette Erdmann; Muredach P Reilly; Sekar Kathiresan; Heribert Schunkert; Philippa J Talmud; Nancy L Pedersen; Markus Perola; Willem Ouwehand; Jaakko Kaprio; Nicholas G Martin; Cornelia M van Duijn; Iiris Hovatta; Christian Gieger; Andres Metspalu; Dorret I Boomsma; Marjo-Riitta Jarvelin; P Eline Slagboom; John R Thompson; Tim D Spector; Pim van der Harst; Nilesh J Samani
Journal:  Nat Genet       Date:  2013-04       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.